| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/2007 | US20070036765 determining whether a first population of human cells comprises CD34+CD38-Lin- hematopoietic stem cells isolated from normal human bone marrow, cord blood, and peripheral blood stem cell preparations |
| 02/15/2007 | US20070036763 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070036762 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer |
| 02/15/2007 | US20070036760 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 02/15/2007 | US20070036759 Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same |
| 02/15/2007 | US20070036758 Mutants of vaccinia virus as oncolytic agents |
| 02/15/2007 | US20070036756 Method for treating ischemic diseases |
| 02/15/2007 | US20070036752 IL-2 fusion proteins with modulated selectivity |
| 02/15/2007 | US20070036750 MCP1 fusions |
| 02/15/2007 | US20070036727 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "cest" applications |
| 02/15/2007 | US20070036720 Radiolabelled metal transport protein as imaging agent |
| 02/15/2007 | US20070036719 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA) |
| 02/15/2007 | DE102005037349A1 Verfahren für die kontinuierliche zielgerichtete Evolution von Proteinen in vivo Process for the continuous evolution of targeted proteins in vivo |
| 02/15/2007 | CA2659961A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | CA2659958A1 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/15/2007 | CA2625933A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 02/15/2007 | CA2618796A1 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 02/15/2007 | CA2618779A1 Phosphoadenylyl sulfate reductase gene and use thereof |
| 02/15/2007 | CA2618765A1 Methods for treating b-cell malignancies using taci-ig fusion molecule |
| 02/15/2007 | CA2618763A1 Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules |
| 02/15/2007 | CA2618554A1 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 02/15/2007 | CA2618396A1 Tissue protective peptides and uses thereof |
| 02/15/2007 | CA2618273A1 Expression of an active carrier for xylose in genetically modified saccharomyces cerevisiae |
| 02/15/2007 | CA2618047A1 A novel peptide involved in energy homeostasis |
| 02/15/2007 | CA2617960A1 A novel nucleic acid encoding a novel protein of candida albicans and uses thereof |
| 02/15/2007 | CA2617911A1 Killing human lymphoma and leukemia cancer cells and tcr-activated normal human cells by dopamine d1r agonists |
| 02/15/2007 | CA2617714A1 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 02/15/2007 | CA2617506A1 Immunogenic constructs useful for treating mycobacterium avium subspecies paratuberculosis (map) infection |
| 02/15/2007 | CA2617064A1 Conjugates of a g-csf moiety and a polymer |
| 02/15/2007 | CA2616187A1 Human growth hormone conjugated with biocompatible polymer |
| 02/15/2007 | CA2616069A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 02/15/2007 | CA2616041A1 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition |
| 02/15/2007 | CA2614838A1 Method for the purification of alpha-1 proteinase inhibitor (a1pi) |
| 02/15/2007 | CA2613482A1 Methods and compositions for diagnosis and treatment of influenza |
| 02/15/2007 | CA2611946A1 Expression vector and methods of producing high levels of proteins |
| 02/15/2007 | CA2608512A1 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 02/15/2007 | CA2606894A1 Novel compounds as glp-i agonists |
| 02/14/2007 | EP1752544A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same |
| 02/14/2007 | EP1752540A2 Non-human mutant mammals deficient in sigma receptors and their applications |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752533A1 Fusion proteins between plant cell-wall degrading enzymes, and their uses |
| 02/14/2007 | EP1752472A2 Chimeric amyloid beta peptides |
| 02/14/2007 | EP1752470A1 Gag binding proteins |
| 02/14/2007 | EP1752469A2 Long lasting fusion peptide inhibitors for HIV infection |
| 02/14/2007 | EP1752468A1 Method for the production of empty viral capsids in yeasts, said capsids comprising proteins derived from pvp2 of the virus that causes infectious bursal disease (ibdv) |
| 02/14/2007 | EP1752466A2 Process of purification of hcg and recombinant hcg purified by that method |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1752040A1 Isolation of the t-complex distorters and applications thereof |
| 02/14/2007 | EP1751554A1 Method for screening and compositions for treating cancers |
| 02/14/2007 | EP1751301A2 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment |
| 02/14/2007 | EP1751300A2 T-cell death-inducing epitopes |
| 02/14/2007 | EP1751291A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 02/14/2007 | EP1751290A2 Alphavirus replicon packaging constructs |
| 02/14/2007 | EP1751289A1 Tc-83-derived alphavirus vectors, particles and methods |
| 02/14/2007 | EP1751288A2 Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production |
| 02/14/2007 | EP1751284A2 Method and compositions for detecting botulinum neurotoxin |
| 02/14/2007 | EP1751282A2 Production of host cells containing mutiple integrating vectors by serial transduction |
| 02/14/2007 | EP1751189A1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 02/14/2007 | EP1751188A1 Splice variant of unc5h2 |
| 02/14/2007 | EP1751187A2 Canine cd20 compositions |
| 02/14/2007 | EP1751186A2 Carrier conjugates of tnf-peptides |
| 02/14/2007 | EP1751185A2 Tgf derepressors and uses related thereto |
| 02/14/2007 | EP1751184A2 Fgf-21 fusion proteins |
| 02/14/2007 | EP1751183A2 Fas associated factor 1 |
| 02/14/2007 | EP1751182A1 A novel human card-only protein that inhibits pro-il-1 beta; maturation |
| 02/14/2007 | EP1751181A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS |
| 02/14/2007 | EP1751179A2 Casein derived peptides and therapeutic uses thereof |
| 02/14/2007 | EP1751178A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 02/14/2007 | EP1751177A2 Cross-linkable glycoproteins and methods of making the same |
| 02/14/2007 | EP1751175A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| 02/14/2007 | EP1751174A1 Inhibitors of regiii proteins as asthma therapeutics |
| 02/14/2007 | EP1751094A2 Beta-peptides |
| 02/14/2007 | EP1750983A2 High protein soybean meal |
| 02/14/2007 | EP1750773A1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 02/14/2007 | EP1750761A1 Medical uses of carrier conjugates of non-human tnf-peptides |
| 02/14/2007 | EP1750754A2 Human glp-1 mimetibodies, compositions, methods and uses |
| 02/14/2007 | EP1750750A1 Method of stabilizing proteins |
| 02/14/2007 | EP1750749A2 Il-28 and il-29 cysteine mutants for treating viral infection |
| 02/14/2007 | EP1750747A1 Soluble lfa-3 polypeptide for treating viral disorders |
| 02/14/2007 | EP1750746A1 Methods of using il-1 antagonists to treat autoinflammatory disease |
| 02/14/2007 | EP1750743A2 Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases |
| 02/14/2007 | EP1750733A1 METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII |
| 02/14/2007 | EP1750674A2 Microparticles for oral delivery |
| 02/14/2007 | EP1750528A2 Alpha-msh-antagonist didpeptide conjugates |
| 02/14/2007 | EP1670813A4 Rho antibody and tag to purify cell surface proteins |
| 02/14/2007 | EP1656452B1 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 02/14/2007 | EP1576144A4 Proteorhodopsin mutants with improved optical characteristics |
| 02/14/2007 | EP1506234B1 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 02/14/2007 | EP1456363B1 Alleles of the siga gene from coryneform bacteria |
| 02/14/2007 | EP1442059B1 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 02/14/2007 | EP1423423B1 Methods for construction and screening of libraries of chemokine variants |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1315750B1 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 02/14/2007 | EP1283214B1 Novel collectins |
| 02/14/2007 | EP1242452B1 Chimeric natriuretic peptides |
| 02/14/2007 | EP1206495B1 Chimeric polypeptides, method for production and uses thereof |
| 02/14/2007 | EP1200458B1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/14/2007 | EP1143000B1 Screening method |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP1035780B1 Method for purifying heat shock peptides complexes |